Rare Renal Disorders

Pharmacotherapies

Explore facts and recommendations for pharmacological treatments for rare renal disorders.

Filters

We are still gathering material for this library.

Please check again soon.

We're sorry

We didn't find any resources that match your selection.

Please adjust your filter(s) and try again.

 
Preview
rare-renal-lungs-icon-24px Rare Renal Disorders PDF

PHYOX Clinical Development Program

An overview of the PHYOX clinical development program evaluating nedosiran for the treatment of primary hyperoxaluria.

 
Preview
rare-renal-lungs-icon-24px Rare Renal Disorders PDF

PHYOX2 infographic

This infographic provides an overview of PHYOX2, the pivotal randomized study of nedosiran in PH1 or PH2

 
Preview
rare-renal-lungs-icon-24px Rare Renal Disorders PDF

PHYOX3 infographic

This infographic summarizes the safety and efficacy of nedosiran in patients with PH1 based 2.5 year interim analysis of the PHYOX3 trial

Discover more rare renal disorder-related content or search the Exchange

Find more information

Find product information

Explore our portfolio of products for treating rare renal disorders, including prescribing information, safety data sheets and storage and stability information.

View products

Continuing education

Explore accredited education opportunities for rare renal disorders, supported by Novo Nordisk and provided by third-party organizations.

Explore CE

Top

This medical content was developed independently by a third party via an educational grant. This material is copyright protected and is provided here with permission for educational and informational purposes only and is not certified for continuing education credits.

Continue

You are now leaving the Novo Nordisk Scientific Exchange website.

Our Privacy Policy applies only to this and other websites maintained by Novo Nordisk. Links are provided as a public service and for informational purposes only. No endorsement is made or implied. Click "Continue" to leave this site.

Continue

GATED INTERSTITAL  

You are now leaving the Novo Nordisk Scientific Exchange website.

Our Privacy Policy applies only to this and other websites maintained by Novo Nordisk. Links are provided as a public service and for informational purposes only. No endorsement is made or implied. Click "Continue" to leave this site.

ACCESS DENIED

Our Privacy Policy applies only to this and other websites maintained by Novo Nordisk. Links are provided as a public service and for informational purposes only. No endorsement is made or implied. Click "Continue" to leave this site.